Novartis



Ebitda Veränderung Datum
AbbVie USD 4.4B 2.52B 2025-03
Alcon AG USD 463M 51M 2025-03
Almirall EUR 76.3M 8.43M 2025-03
Amgen USD 3.6B 147M 2025-06
AstraZeneca USD 4.96B 127M 2025-06
Autolus Therapeutics Ltd -62937000 10.93M 2025-03
Bayer EUR 236M 3.35B 2025-06
Biogen USD 1.01B 456.5M 2025-06
Bristol-Myers Squibb USD 3.27B 1.63B 2025-06
Eli Lilly USD 7.5B 3.34B 2025-06
Fresenius EUR 828M 88M 2025-06
Fresenius Medical Care EUR 871M 282M 2025-06
Galapagos EUR -158708000 177.84M 2025-03
Genmab DKK 376M 172M 2025-06
Gilead Sciences USD 3.4B 797M 2025-06
GlaxoSmithKline GBP 3.18B 45M 2025-06
GRIFOLS EUR 347.24M 58.35M 2025-06
Hikma Pharmaceutical USD 369M 84M 2024-12
J&J USD 7.88B 1.76B 2025-03
Lonza CHF 1.01B 139M 2024-12
Merck EUR 1.46B 45M 2025-06
Merck USD 7.74B 625M 2025-03
Novartis USD 6.17B 339M 2025-06
Novartis USD 6.82B 1.31B 2024-12
Novo Nordisk 38.28B 4.34B 2025-06
Orion EUR 118.6M 27.1M 2025-06
Pfizer USD 5.32B 889M 2025-06
Philips EUR 747M 174M 2025-06
Recordati EUR 226.19M 21.6M 2025-06
Regeneron Pharmaceuticals USD 1.66B 926.5M 2025-06
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 1.89B 971M 2025-06
UCB EUR 1.37B 715M 2024-12


Novartis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.